Abstract: Hepcidin, a 25 amino acid peptide hormone containing a complex network of four disulfide bonds is the hormone regulator of iron homeostasis. Three bridges synthetic peptide analogs have been prepared following two synthetic strategies and two oxidation procedures: i) a microwave-assisted solid phase synthesis followed by air oxidation of the six free cysteines ii) a manual solid phase synthesis followed by stepwise deprotection and oxidation of cysteine pairs. All the peptides with different connectivities have been characterized by MALDI ToF spectrometry, and tested for their ability to degrade the cellular iron exporter, ferroportin. While linear peptides are inactive, the one-bridge and two-bridge peptides retaining protected cysteines by bulky substituents are active. Similarly, the three-bridge peptides are active irrespective of their disulfide connectivities.
INTRODUCTION
Hepcidin, a 25 amino acid (aa) peptide hormone containing a complex network of four disulfide bonds, was first discovered as an antimicrobial peptide of the defensin family [1, 2] . Hepcidin was then shown to play a key role in the regulation of iron homeostasis [3, 4] . This peptide regulates iron export from enterocytes and macrophages by binding ferroportin, the sole known cellular iron exporter, leading to its internalization and degradation, and thus preventing iron release from iron-storing and transporting cells [5] . Hepcidin is synthesized as an 84-aa pre-propeptide, with a 24-aa Nterminal signal peptide, which is cleaved off across the endoplasmic reticulum, resulting in a 60-aa propeptide. Further processing of pro-hepcidin involves a furin type convertase , that cleaves pro-hepcidin at the consensus furin site RX(K/R)R, conserved in mammals and fish [6] and releases the biologically active hepcidin-25. Recently, it has been shown that pro-hepcidin, unless processed by furin, is unable to degrade ferroportin [7] . In addition, N-terminus of hepcidin is important for its iron-regulatory activity since the first five amino acids, in the N-terminal part of hepcidin-25, are essential for its interaction with ferroportin [8] . Deletion of these 5 residues up to hepcidin-20 leads to a complete loss of activity. It has been proposed that the interaction between hepcidin and ferroportin results in a covalent binding that involves disulfide exchange between one of the disulfide bonds of hepcidin and Cys326 of ferroportin, even though multiple disulfide bonds of hepcidin might be capable of forming a contact with ferroportin [9] .
Hepcidin genes have been identified in several species including mouse, rat, pig, dog and fish, and all these peptides conserved the same folding pattern involving the eight cysteines [4, [10] [11] [12] [13] [14] [15] . The first NMR solution structure of human hepcidin, reported by Hunter et 22 was also prepared. Disulfide bonds were formed using either a random oxidation of cysteines or a stepwise regioselective formation of the bridges, following a microwaveassisted or a manual solid phase peptide synthesis.
MATERIALS AND METHODS

Chemicals
Fmoc-Thr-(tBu) Wang resin, 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyl-uronium hexafluorophosphate (HBTU), N-hydroxybenzotriazole (HOBt), benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP), the pseudoproline Fmoc-Asn(Trt)-Ser(psiMe,Mepro)-OH and N--Fmoc-amino acids were purchased from VWR-NovaBiochem (Läufelfingen, Switzerland). Amino acids were protected as follows: tert-butyl (tBu) for threonine, glutamic acid, serine; tert-butoxycarbonyl (Boc) for lysine, glutamine; trityl (Trt) for glutamine and asparagine; Trt, tBu and acetamidomethyl (Acm) for the cysteines.
N-methylpyrrolidone (NMP), piperidine, dichloromethane (DCM), dimethylformamide (DMF), pyridine, acetonitrile, and anhydride acetic acid were purchased from SDS (Peypin, France); Trifluoroacetic acid (TFA), triisopropylsilane (TIS), 2,4,6-trimethylpyridine (collidine), ethan-1,2-dithiol (EDT), anisole and N,N-diisopropylethylamine (DIEA) from Aldrich (Saint Quentin Fallavier, France).
PEPTIDE SYNTHESIS
The manual syntheses were performed according to the following procedure. The linear precursor with protected side chains was assembled manually by solid-phase peptide synthesis (SPPS) on Wang resin low load, preloaded with a threonine substituted at 0.27 mmol.g -1 by using Fmoc chemistry. Each deprotection of Fmoc groups was performed twice with 20% piperidine / DMF (v/v), and checked by UV/Vis spectroscopy at 301 nm. Coupling was performed using 1:1:1:2 amino acid/PyBOP/HOBt/DIEA in 5 mL of DMF (30 min) for all amino acids, except Fmoc-Cys(Trt)-OH, Fmoc-Cys(Acm)-OH, and Fmoc-Cys(tBu)-OH, for which collidine was used instead of DIEA. Resin was filtered, washed abundantly with DMF and DCM, and dried. Each coupling was performed twice and checked with Kaiser Test, except for the proline and cysteines residues, and finally followed by treatment with 6 mL of DMF/pyridine/ Ac 2 O, 7/2/1 (v/v/v) for 2 min. Resin and peptide were washed abundantly with DMF and finally Fmoc deprotection was achieved with DMF/piperidine 4/1 (v/v).
The microwave-assisted syntheses (MW-SPPS) were performed on a CEM microwave peptide synthesizer (CEM Liberty, microwave power 65 W, temperature max 75°C). All the cysteines were protected with Trt. The polyethylene glycol-polystyrene (PEG-PS) resin was preloaded with a threonine substituted at 0.20 mmol.g -1 . Fmoc groups were deprotected with 20% piperidine/DMF (v/v). Coupling was achieved using 1:1:1 amino acid/HBTU/collidine in DMF. DMF top and bottom washes were performed between deprotection and coupling steps. Double amino acid coupling cycles were used for the 9 amino acids in the N-terminal part.
CLEAVAGE FROM THE RESIN
The final peptide was cleaved from the resin, and the side-chain protecting groups were removed by treatment with TFA/EDT/TIS/Water (94/2.5/2/1.5, v/v/v/v). The solution was prepared at 0°C, and typically, 10 mL was mixed with 0.6 g of peptide containing resin. Deprotection and cleavage were complete after 120 min stirring. After filtration, 1 mL of TFA/DCM (1/9, v/v) was added to the peptide solution to eliminate any remaining resin. The crude peptide was precipitated by adding 100 mL of cold diethyl ether and collected after centrifugation by filtration. It was further dissolved in an aqueous solvent containing 20% to 30% acetonitrile and 0.1% TFA and was lyophilized.
DISULFIDE BOND FORMATION
Oxidation of Free Thiol: Thermodynamic Equilibration of the Bridges
The crude peptides obtained by microwave assisted peptide synthesis were dissolved at a concentration of 0.1 mg/mL in a mixture of DMSO/H 2 O 80/20 adjusted at pH 8 with an aqueous NH 3 solution and oxidized upon stirring for 18 h at room temperature as previously described [8] . Following oxidation, the mixtures were diluted in water, lyophilized, and the resulting peptides subjected to MALDI-ToF mass spectrometry analysis.
Regioselective Disulfide Bonds Formation
Formation of the Cys 7 -Cys 23 Bridge
After cleavage and deprotection from the resin, the peptide issued from the manual synthesis (carrying 2 free cysteines at positions 7 and 23) was dissolved in a mixture of DMSO/H 2 O (1/2, v/v) and air oxidized upon stirring for 18 h to allow the Cys 7 -Cys 23 disulfide bond formation. After dilution in water, the solution was lyophilized, and the resulting peptide was analyzed by mass spectrometry.
Deprotection and Oxidation of Acetamidomethyl (Acm)
Protected Cysteine: Formation of the Second S-S Bridge 120 μL of 20% iodine solution in CH 3 OH was added in one portion to an 80% aqueous AcOH solution (5 mL) of the peptide (0.96 μM), and the mixture was stirred at 25°C for 60 min. Excess iodine was reduced with 1 M ascorbic acid in water. After concentration under vacuum, the solution (1mg/mL) was loaded on to Sephadex G25, and the peptide was eluted with 50% AcOH. The desired collected fractions were lyophilized. Complete disulfide bond formation was confirmed by MALDI-ToF mass spectrometry analysis.
Deprotection and Oxidation of Tert-butyl (tBu) Protected Cysteines: Formation of the Third S-S Bridge
In a typical experiment, the crude peptide was dissolved in a solution of TFA/DMSO/anisole (97.9/2/0.1, v/v/v) to the approximate concentration of 0.2 mg/mL and the mixture was stirred for 60 min at room temperature. MALDI-ToF analysis of the peptide showed that the tBu groups were cleaved and that oxidation in disulfide was complete.
The peptides were characterized by HPLC (Gilson, Villiers-le-Bel, France) on a reverse phase Vydac C18 column (250 mm x 4.6 mm, 300 Å pores; Grace, Templemars, France) equilibrated with solvent A (H 2 O, 0.1% TFA). Peptides were eluted at a flow rate of 1 ml/min with a gradient of B (acetonitrile, 0.1% TFA) versus A (H 2 O, 0.1% TFA) and detected by monitoring the absorbance at 214 nm. The elution gradient was 0 to 80% B over 17 min. For each peptide, the major peak between 10 and 17 min was collected and the purity was controlled by MALDI-ToF mass spectrometry.
The amount of free thiol was determined following the Ellman test [18] . A titration curve was recorded using 5,5'-dithiobis(2-nitrobenzoic acid) (5 mM) and glutathione (4-200 M in Tris buffer 100 mM pH 7.3-7.5) as standard by measuring the absorbance at 412 nm ( 13600 M -1 cm -1 ) on an Uvikon 420 spectrophotometer (Kontron, Zurich, Switzerland). Free thiol concentration was measured on peptide samples using at least 20 μM DMSO solutions. When using DMF instead of DMSO, the wavelength is shifted to 480 nm.
MASS SPECTROMETRY ANALYSIS
Matrix Assisted Laser Desorption and Ionization Time of Flight (MALDI-ToF) mass spectrometry was performed on Voyager. MALDI-ToF spectra were obtained in a reflectrondelayed extraction source and recorded with a voyagerDEPro mass spectrometer (PerSeptive Biosystems, Framingham, MA, USA). Dried-droplet method was used to deposit peptide on sample plate using -cyano-4-hydroxycinnamic acid (CHCA) in acetonitrile/water/trifluroacetic acid (50:50:0.1%). Droplets were then dried at room temperature. The peptides masses were measured after internal calibration with three external standards (ACTH (clip 1-17 
CELL CULTURE AND WESTERN BLOT ANALYSIS
The mouse monocyte-macrophage cell line J774 was cultured as described previously [19] . Cells were grown in Dulbecco's Modified Eagle's Medium (DMEM/Glutamax, Invitrogen) supplemented with 10% heat-inactivated lowendotoxin fetal bovine serum (Invitrogen), 100 U/ml penicillin and 100 g/ml streptomycin at 37°C in 5% CO 2 . To increase ferroportin distribution to the cell membrane prior to peptides treatment, cells were incubated for 16 h with a Fenitrilotriacetate aqueous solution (Fe-NTA: FeCl 3 200 μM -NTA 800 μM). The peptides were incubated at 100 and/or 700 nM for 5 h, membrane protein were extracted and submitted to SDS PAGE and the presence of ferroportin at the macrophage membrane was detected by western blot analysis using a rabbit polyclonal Anti-ferroportin antibody as previously described [20] . Synthetic human hepcidin (Peptides International) was used as control.
RESULTS AND DISCUSSION
Synthesis of Peptides and Disulfide Bond Formation
We first tried to perform the synthesis of linear precursor (with six free cysteines) of m-[A 10 , A 22 ]-Hepc-1 ( Fig. 1) following Fmoc chemistry on a Peptide Synthesizer using a polyethylene glycol-polystyrene (PEG-PS) resin and a double coupling mode with 0.1 mmol of resin and a tenfold excess of amino acids, as previously described for human hepcidin [8] . The MALDI-ToF spectrum of the crude product showed the expected peak for the 25-aa peptide at m/z 2697.84 (corresponding to the [M+H] + ). However, many other peaks attributed to truncated peptides were also observed. HPLC purification of the crude peptide provided the expected peptide but in a very low yield (<1%) despite many attempts to improve the synthesis. Therefore we decided to investigate different strategies to obtain the desired peptide. One possible explanation for such a low yield is that mouse hepcidin, with only two basic residues (pHi = 7.7) instead of four for human hepcidin (pHi = 8.22), is more hydrophobic and has a high propensity to aggregate [20] .
So, we decided to turn to the microwave-assisted solidphase peptide synthesis, which is known to reduce the reaction times and to increase the purity of the final peptide. It was recently shown that the microwave irradiation was particularly adapted to the synthesis of highly hydrophobic peptides by improving the efficacy of both deprotection and coupling steps that are limited by aggregation [21] [22] [23] [24] . This can be explained as follows: in peptides, the N-terminal amine group and peptide backbone are polar, and therefore tend to align with the alternating electric field of the microwave. During peptide synthesis, this can help break up the chain aggregation through intra-and inter-chain associations and can facilitate the access of the reagent to the solid phase matrix. Synthesis of m-[A 10 Fig. 2C and 2D , and Table 1 ). In addition, no free cysteines could be detected using the Ellman's reagent showing that all the cysteines were effectively involved in disulfide bonds (data not shown).
This random oxidation of the cysteines over 18 h can promote an equilibrium between all the Cys-Cys bonds and finally the most stable one is isolated. As the Cys 13 [16] . Stepwise introduction of disulfide bonds using orthogonal protection of cysteine residues has been previously reported [25] [26] [27] . Cuthbertson et al. have described the formation of the four disulfide bridges of an -conotoxin peptide by using four different protecting groups Trt, Acm, tBu and MeBzl in two one-pot oxidations [26] . This procedure greatly reduced the number of handling steps and the subsequent loss of material associated with repetitive purifications of partially folded intermediates. By analogy, we used this strategy to form the three-disulfide bonds of the hepcidin analogs. The aim was to compare the biological activities of the same peptides folded according to a random or a regioselective oxidation of the cysteines.
Since the microwave equipment was not easily accessible, the linear peptide was handmade using solid-phase synthesis. (Fig. 1) the cysteines residues were pair wise protected by Trt, Acm and tBu, respectively. Synthesis of m-[A 10 , A 22 ]-Hepc-1 precursor was performed in a double coupling mode for all residues with 0.081 mmol of resin and a threefold excess of aminoacids. In addition, a pseudoproline was introduced to increase the coupling yield at position Ser 9 -Asp 10 . Each coupling step was checked by the Kaiser test (or ninhydrin test). (Fig. 3A, Table 1 ).
The linear precursor of m-[A 10 , A 22 ]-Hepc-1 obtained from this manual solid-phase synthesis was pure enough to be used in the first oxidation step without HPLC purification. Upon cleavage from the resin, Cys 7 and Cys 23 bearing Trt groups were deprotected and the first disulfide bond was formed through DMSO oxidation for 24 h (one bridge m-[A 10 , A 22 ]-Hepc-1). Then iodine oxidation under acidic conditions promotes concomitant Acm deprotection and cysteine oxidation leading to the formation of the second disulfide bond. After reduction of excess iodine with ascorbic acid, and purification over sephadex G25, the two bridges m-[A 10 , A 22 ]-Hepc-1 was lyophilized. Finally, the tBu groups were cleaved in TFA in the presence of anisole as scavenger, and the free cysteines were oxidized with DMSO generating the last disulfide bond and the three bridges peptide, m-[A 10 , A 22 ]-Hepc-1. The one, two and three disulfide bridge containing peptides were analyzed by MALDI-ToF mass spectrometry (Table 1) , and the mass spectra exhibit the expected peak corresponding to [M + H] + at m/z 2949.14 (one bridge Fig. 3B) , at m/z 2805.16 (two bridges Fig. 3C) and at m/z 2691.03 (three bridges, Fig. 3D) . The intermediate peptides as well as the final m-[A 10 , A 22 ]-Hepc-1 were also analyzed, as previously described [20] , by SDS-PAGE under nonreductive conditions to verify the absence of aggregation. As expected, all peptides run as a monomeric 3 kDa form (data not shown).
The success of this method prompted us to prepare another three-bridge analog corresponding to Jordan's connectivities, m-[A 11 , A 19 ]-Hepc-2, in which 2 alanine residues replaced Cys11 and Cys19 of m-Hepc. This peptide has no vicinal cysteines involved in a disulfide bond. The resulting 
Activity of the Peptides Towards Ferroportin
The iron-related bioactivity of the peptides was tested in Fe-NTA treated J774 macrophages for their ability to degrade Ferroportin. As shown by western blot, only iron treated macrophage cells express detectable amount of membrane bound Ferroportin (Fig. 5, lane 1 versus 2) . Human synthetic 25-aa mature hepcidin used as control at 100 nM led to a complete disappearance of ferroportin (Fig. 5, lane  3) . The activity of the peptides was determined at 100 and 700 nM. This includes: m-[A 13 , A (Fig. 5, lanes 8-11 respectively) , and finally the peptide prepared according to Jordan's connectivities m-[A 11 , A 19 ]-Hepc-2 with three bridges (Fig. 5, lanes 12 and  13) . The two hepcidin analogs prepared by MW-SPPS followed by a random oxidation of the cysteines are active at 700 nM (Fig. 5, lanes 5 and 7) . For the peptides prepared by manual synthesis, the linear peptide corresponding to the precursor of m-[A 10 , A 22 ]-Hepc-1 with two free cysteines and two pairs of cysteines protected by Acm and by tBu is inactive (Fig. 5, lane 8) . However, at 700 nM, the peptides with one, two and three disulfide bonds are active (Fig. 5,  lanes 9-11) , as well as the three-bridge analog m-[A 11 , A 19 ]-Hepc-2 (Fig. 5, lane 13) . This result confirms, as previously described by Nemeth et al. using one bridge peptide where alanine residues replaced the other cysteines [8] , that the ability of hepcidin analogs to degrade ferroportin requires the presence of only one disulfide bond. However, in our one bridge peptide, the other cysteines, while present were always protected. Our results obtained with the manually synthesized peptides demonstrate that intermediate forms with one and two disulfide bridges retain their ability to promote ferroportin degradation despite the presence of bulky protecting groups on the remaining cysteines. Clearly these substituents do not prevent the interaction of the N-terminal part of the peptide with ferroportin, a prerequisite for its degradation [8] .
To prepare a peptide with a disulfide bond between two vicinal cysteines is very difficult, as underlined by Jordan's et al. [17] . However, this type of connectivity is found in some proteins and is accompanied by the formation of a tight turn of the protein backbone [28] . None of the three disulfide bridges analogs of m-Hepc-1, which are active, presents Jordan's connectivities. [17] . Our results demonstrate that the exact nature of the disulfide bonds is not so important for hepcidin activity. The key is to ensure a correct folding of the peptide that allows the interaction of the N-terminal part of the peptide with ferroportin.
CONCLUSION
In this study we have examined several methods for the chemical synthesis and the folding of three bridge analogs of mouse hepcidin. The best results, in terms of purity and overall yield, are obtained using manual or microwaveassisted solid phase peptide synthesis. In both cases, the linear peptides obtained after cleavage from the resin exhibit only one peak in MALDI-ToF mass spectrometry analysis and can be used without further tedious HPLC purifications, which lead to serious aggregation of the peptides. Random oxidation of the peptide with six free cysteines or controlled oxidation of cysteine pairs, using selective protection and deprotection steps, yields pure oxidized three bridges analogs of mouse hepcidin. These analogs as well as the synthetic intermediates were assayed for their potency to degrade ferroportin. The presence of at least one disulfide bridge is required for activity and interestingly the presence of bulky protecting groups on the other cysteines does not prevent activity. Finally in the three disulfide bridges analogs, the disulfide connectivities do not seem to play a key role for activity since all three disulfide bridge peptides, m-[A 10 
